MDxHealth SA (OTCMKTS:MXDHF – Get Free Report) fell 9.1% during trading on Monday . The company traded as low as $0.25 and last traded at $0.25. 300 shares were traded during mid-day trading, a decline of 70% from the average session volume of 1,000 shares. The stock had previously closed at $0.28.
MDxHealth Price Performance
The stock’s 50 day moving average price is $0.43. The company has a debt-to-equity ratio of 1.45, a current ratio of 1.25 and a quick ratio of 1.19.
MDxHealth Company Profile
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications.
See Also
- Five stocks we like better than MDxHealth
- What to Know About Investing in Penny Stocks
- Real Estate Stock Signals a Boom in Manufacturing Activity
- Why Are Stock Sectors Important to Successful Investing?
- This Medical Giant’s Stock Rebounds: A 15% Upside Is the Minimum
- Trading Halts Explained
- Financial Giant’s Shares Soar on EPS Beat and Record Asset Levels
Receive News & Ratings for MDxHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDxHealth and related companies with MarketBeat.com's FREE daily email newsletter.